drugset / Trial / NCT05903963
Evaluation of Renal Protection Of Dexmedetomidine Versus Midazolam As a Sedative For Septic Patients In Intensive Care Unit
RandomizedParallel-groupDouble-blindSupportive care
Summary
Evaluation of Renal Protection Of Dexmedetomidine Versus Midazolam As a Sedative For Septic Patients In Intensive Care Unit
Timeline
- Start
- 2023-05-22
- Primary completion
- 2023-11-12
- Completion
- 2023-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | Intravenous |
| Comparator | Dexmedetomidine | Other / unclassified | 0.3 ug/kg | Intravenous |
| Comparator | Midazolam | Small molecule | 0.03 mg/kg | — |
| Comparator | Midazolam | Small molecule | 0.2 mg/kg | — |